Press Release Summary:
Targeting pharmaceutical and medical device markets, PRO FlexiPURE™ addresses trace contaminants found in film structures. Solution reduces sealant-side extractables (in water, alcohol and hexane) by 60% as well as time and effort neededÂ to complete drug submission packaging requirements. With low extractable profile that minimizes compounds requiring identification, analysis, and monitoring, aluminum foil barrier provides low moisture and oxygen transmission ratesÂ and light penetration.
Original Press Release:
Ampac Announces Low Extractable Barrier Lamination - PRO FlexiPURE(TM)
Cincinnati, OH – Ampac, a division of ProAmpac, announces a new low extractable barrier lamination, PRO FlexiPURETM, which enhances the existing family of successful barrier drug and medical device overwrap laminations for the pharmaceutical and medical device markets.
As analytical equipment has improved, detection limits of trace contaminants have lowered. In filing new drug applications using packaging film, these detectable trace compounds must be included in the drug submission process, identified, risks analyzed, and monitored, all of which costs pharmaceutical companies time and money. The fewer of these components that are realized in the film structure, the less time and money needed to be spent on this portion of a new drug submission.
To strengthen their existing family of successful barrier drug overwrap laminations, Ampac is introducing a low extractable barrier lamination called PRO FlexiPURE, which addresses the amount of trace contaminants found in film structures. This product line extension to Ampac’s drug overwrap films Flexi 2114, Flexi 6554/6702, and Flexi-Free 7200, has been independently tested and proven to reduce sealant side extractables by 60% over solvent based laminations. This reduction of sealant side extractables (in water, alcohol and hexane) by 60% produces a low extractable, clean lamination profile.
The benefit of PRO FlexiPURE to the customer is a reduction in time and effort needed in completing packaging requirements of drug submissions. With a low extractable profile, there are fewer compounds to be identified, analyzed and monitored. In addition, the aluminum foil barrier provides excellent shelf life, a low moisture transmission rate, low oxygen transmission rate and low light penetration.
Ampac Senior Market Manager, Craig Livingston, states “As a company, Ampac’s continued focus and ultimate goal is to supply our customers with new technology that provides value while improving packaging performance for their product. We are delighted to have achieved our goal with the new low extractable barrier lamination PRO FlexiPURE.”
Ampac is a division of ProAmpac and is part of the U.S. Flexibles Division. Ampac drives packaging transformation and performance by creating packages that are more innovative, progressive and dynamic than those used by competitive brands. Ampac’s comprehensive approach to packaging is a balance of rigorous, technology-driven thinking and exceptional creativity.
ProAmpac is steadfast in their unwavering commitment to provide creative packaging solutions, industry-leading customer service and award-winning innovation to a diverse global marketplace. It is a diversified global packaging company with over 2,500 employees and 18 manufacturing centers in North America, Europe and Asia. For more information, visit our website at: www.ProAmpac.com.
Please forward inquiries to:
12025 Tricon Rd
Cincinnati, OH 45246
Phone: (513) 671-1777
Fax: (513) 671-2920